Weight loss drugs linked to higher risk of eye damage in diabetic patients
The study found that those who had been taking semaglutide or lixisenatide for at least six months had twice the risk of developing macular degeneration.
The Ozempic universe expands: These drugs also treat fatty liver disease
Ozempic drugs show promise in treating fatty liver disease, halting or reversing its progression, and may provide broader therapeutic effects beyond weight loss.
Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic
"The drug also lowered patients' blood sugar levels by 1.3% on average, while the overall efficacy of orforglipron in promoting weight loss and controlling diabetes has been met with enthusiasm."